Wernicke Encephalopathy From Olfactory Dysfunction After COVID-19 Infection

Neurologist. 2021 Nov 4;26(6):274-275. doi: 10.1097/NRL.0000000000000359.

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide and is caused by infection from the severe acute respiratory syndrome coronavirus-2 pathogen. While COVID-19 most commonly affects the respiratory system, multiple neurological complications have been associated with this pathogen. We report a case of Wernicke encephalopathy in a young girl with poor oral intake secondary to anosmia and dysgeusia after a COVID-19 infection.

Case report: After a recent infection of COVID-19, a 15-year-old girl developed an overwhelming noxious metallic tase resulting in a 30 lb weight loss from being unable to tolerate oral foods. She presented to the hospital 3 months later with bilateral horizontal conjugate gaze palsies, up beating vertical nystagmus, difficulty with limb coordination and gait ataxia. She was found to have a thiamine level of 51 nmol/L (reference range: 70 to 180 nmol/L) and her brain magnetic resonance imaging showed fluid-attenuated inversion recovery and diffusion-weighted imaging changes in the periaqueductal gray and dorsomedial thalami suggestive of Wernicke encephalopathy. She was started on parenteral thiamine replacement and had significant neurological improvement.

Conclusions: As this pandemic continues to progress, more long-term neurological sequelae from COVID-19 such as Wernicke encephalopathy can be expected. Strong clinical suspicion for these complications is needed to allow for earlier diagnosis and faster treatment initiation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • COVID-19*
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Olfaction Disorders*
  • SARS-CoV-2
  • Thiamine Deficiency*
  • Wernicke Encephalopathy* / drug therapy
  • Wernicke Encephalopathy* / etiology